secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q/C TECHNOLOGIES, INC. (QCLS)
CIK:        0001321834
Form:       8-K
Filed at:   2023-04-05T23:59:59+00:00
Accession:  0001493152-23-011038
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

MyMD Pharmaceuticals grants 750,000 stock options to President and CMO Chris Chapman
--------------------------------------------------------------------------------

- Grant of options to purchase 750,000 shares at $1.55 per share to Dr. Chris Chapman, President and CMO.
- Options vest in three equal annual installments starting April 4, 2023.
- Options expire on fifth anniversary of grant date (April 4, 2028).
- Grant approved by compensation committee on April 4, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1321834/000149315223011038/0001493152-23-011038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1321834/000149315223011038/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-011038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer